Shaopeng Yuan1, Shimeng Zhang, Yuanyuan Zhuang, He Zhang, Jinye Bai, Qi Hou. 1. Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Abstract
BACKGROUND/AIMS: Interleukin-17 (IL-17) is a major pro-inflammatory cytokine that initiates and maintains inflammation. However, the molecular mechanisms as to how IL-17 influences endothelial cells to promote neutrophil recruitment are not fully understood. METHODS: Human endothelial cells (HMECs) were stimulated with IL-17, and investigated for proliferation, migration, and tubule formation activities. Transwell chemotaxis and adhesion assays were performed to assess neutrophil recruitment. Cytokine production was measured by Cytokine Array Chip and ELISA. Western blotting and immunofluorescent analysis were used to detect the phosphorylation and translocation of STAT3. Specific inhibitors, small interfering RNA, and phosphorylation mutants were used to confirm that IL-17 induced STAT3 activation via IL-17RA signaling. RESULTS: Activation of HMECs with IL-17 induced STAT3 phosphorylation and nuclear translocation, which were associated with induction of GRO-α, GM-CSF and IL-8, and neutrophil recruitment. Phosphorylation of STAT3 was identified mainly at the tyrosine in position 705 (Y705), and the Y705F mutants attenuated IL-17-mediated STAT3 activation. Moreover, specific inhibitors, FLLL31, or siRNA silencing of STAT3 attenuated HMECs activation, resulting in inhibition of GRO-α, GM-CSF, IL-8 production, and neutrophil recruitment. Furthermore, phosphorylation of STAT3 was identified as downstream of IL-17RA signaling. CONCLUSIONS: IL-17 induced STAT3 activation as a necessary step in endothelial cell activation and neutrophil recruitment.
BACKGROUND/AIMS: Interleukin-17 (IL-17) is a major pro-inflammatory cytokine that initiates and maintains inflammation. However, the molecular mechanisms as to how IL-17 influences endothelial cells to promote neutrophil recruitment are not fully understood. METHODS:Human endothelial cells (HMECs) were stimulated with IL-17, and investigated for proliferation, migration, and tubule formation activities. Transwell chemotaxis and adhesion assays were performed to assess neutrophil recruitment. Cytokine production was measured by Cytokine Array Chip and ELISA. Western blotting and immunofluorescent analysis were used to detect the phosphorylation and translocation of STAT3. Specific inhibitors, small interfering RNA, and phosphorylation mutants were used to confirm that IL-17 induced STAT3 activation via IL-17RA signaling. RESULTS: Activation of HMECs with IL-17 induced STAT3 phosphorylation and nuclear translocation, which were associated with induction of GRO-α, GM-CSF and IL-8, and neutrophil recruitment. Phosphorylation of STAT3 was identified mainly at the tyrosine in position 705 (Y705), and the Y705F mutants attenuated IL-17-mediated STAT3 activation. Moreover, specific inhibitors, FLLL31, or siRNA silencing of STAT3 attenuated HMECs activation, resulting in inhibition of GRO-α, GM-CSF, IL-8 production, and neutrophil recruitment. Furthermore, phosphorylation of STAT3 was identified as downstream of IL-17RA signaling. CONCLUSIONS:IL-17 induced STAT3 activation as a necessary step in endothelial cell activation and neutrophil recruitment.
Authors: Chhinder P Sodhi; Jenny Nguyen; Yukihiro Yamaguchi; Adam D Werts; Peng Lu; Mitchell R Ladd; William B Fulton; Mark L Kovler; Sanxia Wang; Thomas Prindle; Yong Zhang; Eric D Lazartigues; Michael J Holtzman; John F Alcorn; David J Hackam; Hongpeng Jia Journal: J Immunol Date: 2019-10-23 Impact factor: 5.422
Authors: Kim C M Jeucken; Charlotte C N van Rooijen; Yik Y Kan; Lotte A Kocken; Aldo Jongejan; Abraham C I van Steen; Jaap D van Buul; Henric K Olsson; Jan Piet van Hamburg; Sander W Tas Journal: Front Immunol Date: 2022-06-13 Impact factor: 8.786
Authors: M A Kovach; B Singer; G Martinez-Colon; M W Newstead; X Zeng; P Mancuso; T A Moore; S L Kunkel; M Peters-Golden; B B Moore; T J Standiford Journal: Mucosal Immunol Date: 2017-02-08 Impact factor: 7.313